ADD/ADHD News

The Infectious Diseases in Children Symposium will bid farewell this year to a couple of longtime presenters.

ADHD-related medication errors increased almost 300% from 2000 to 2021 among people aged younger than 20 years, a study found.

Young adults who used prescription stimulants as children were not more likely than their peers to use illicit drugs later on, according to a study published in JAMA Network Open.

Rates of current ADHD medication use and ever accessing mental health care were low among children with parent-reported ADHD, according to findings published in JAMA Network Open.

The rate of nonmedical use of prescription stimulants is as high as more than 25% in some U.S. secondary schools, a study found.

The gut microbiomes of children with ADHD differed from those of children without ADHD, findings published in The Journal of Child Psychology and Psychiatry showed.

Azstarys had a favorable safety profile, demonstrated efficacy and was well-tolerated compared to other methylphenidate products over 1 year of treatment, according to research presented in the Journal of Child and Adolescent Psychopharmacology.

A digital medicine company has revealed positive topline results of an expansionist study evaluating the efficacy and safety of a novel therapeutic device to treat adolescents with ADHD.

Children exposed to benzodiazepines and/or nonbenzodiazepines, also known as z-hypnotics, prenatally may not have increased risk for ADHD, according to data published in JAMA Network Open.

A driver training software program reduced the frequency of long glances from the roadway among adolescents with ADHD compared with a control training program, a randomized controlled trial found.